Royce & Associates’s Trustmark TRMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-21,161
Closed -$892K 833
2026
Q1
$892K Buy
21,161
+8,296
+64% +$350K 0.01% 658
2025
Q4
$501K Buy
+12,865
New +$501K 0.01% 705
2022
Q3
Sell
-13,909
Closed -$406K 972
2022
Q2
$406K Sell
13,909
-7,941
-36% -$230K ﹤0.01% 855
2022
Q1
$664K Buy
21,850
+2,338
+12% +$75.7K 0.01% 848
2021
Q4
$633K Buy
+19,512
New +$638K ﹤0.01% 863
2016
Q1
Sell
-40,000
Closed -$922K 1129
2015
Q4
$922K Sell
40,000
-231,800
-85% -$5.61M 0.01% 950
2015
Q3
$6.3M Sell
271,800
-101,000
-27% -$2.39M 0.03% 590
2015
Q2
$9.31M Sell
372,800
-131,500
-26% -$3.21M 0.04% 563
2015
Q1
$12.2M Sell
504,300
-169,500
-25% -$3.93M 0.05% 502
2014
Q4
$16.5M Sell
673,800
-42,500
-6% -$1.01M 0.06% 405
2014
Q3
$16.5M Sell
716,300
-121,600
-15% -$2.88M 0.06% 413
2014
Q2
$20.7M Buy
837,900
+66,600
+9% +$1.59M 0.06% 385
2014
Q1
$19.6M Buy
771,300
+89,000
+13% +$2.21M 0.06% 404
2013
Q4
$18.3M Buy
682,300
+12,000
+2% +$324K 0.05% 441
2013
Q3
$17.2M Buy
670,300
+47,500
+8% +$1.24M 0.05% 439
2013
Q2
$15.3M Buy
+622,800
New +$15.3M 0.05% 452

Other funds holding TRMK

Royce & Associates's TRMK Position: Q2 2026 in Review

Royce & Associates sold out of Trustmark (TRMK) in Q2 2026, closing a stake of 21,161 shares — an estimated $892K sold.

Royce & Associates first reported a position in TRMK in Q2 2013 and held it in 16 quarters. The position peaked at $20.7M in Q2 2014. 291 funds tracked by Wall St. Rank hold TRMK as of Q2 2026.

  • Royce & Associates reported no remaining Trustmark position as of Q2 2026 after selling out during the quarter.
  • Royce & Associates sold 21,161 Trustmark shares in Q2 2026, an estimated $892K.
  • Royce & Associates first reported a position in Trustmark in Q2 2013 and held it in 16 quarters.
  • Royce & Associates's Trustmark position peaked at $20.7M in Q2 2014.
  • 291 funds tracked by Wall St. Rank held Trustmark as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.